Clinical Trials List
Protocol Number104-4830A
2015-10-01 - 2017-09-30
Phase II
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 陳嘉祥 Division of Psychiatry
- Chia-Yi Liu Division of Psychiatry
- Kun-Ju Lin Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
0 participants
